LYL1
From Wikipedia, the free encyclopedia
|
Lymphoblastic leukemia derived sequence 1
|
||||||||||||||
| Identifiers | ||||||||||||||
| Symbol(s) | LYL1; | |||||||||||||
| External IDs | OMIM: 151440 MGI: 96891 HomoloGene: 4078 | |||||||||||||
|
||||||||||||||
| RNA expression pattern | ||||||||||||||
| Orthologs | ||||||||||||||
| Human | Mouse | |||||||||||||
| Entrez | 4066 | 17095 | ||||||||||||
| Ensembl | ENSG00000104903 | ENSMUSG00000034041 | ||||||||||||
| Uniprot | P12980 | Q4FK84 | ||||||||||||
| Refseq | NM_005583 (mRNA) NP_005574 (protein) |
NM_008535 (mRNA) NP_032561 (protein) |
||||||||||||
| Location | Chr 19: 13.07 - 13.07 Mb | Chr 8: 87.59 - 87.59 Mb | ||||||||||||
| Pubmed search | [1] | [2] | ||||||||||||
Lymphoblastic leukemia derived sequence 1, also known as LYL1, is a human gene.[1]
[edit] References
[edit] Further reading
- Xia Y, Brown L, Yang CY, et al. (1992). "TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia.". Proc. Natl. Acad. Sci. U.S.A. 88 (24): 11416–20. PMID 1763056.
- Kuo SS, Mellentin JD, Copeland NG, et al. (1991). "Structure, chromosome mapping, and expression of the mouse Lyl-1 gene.". Oncogene 6 (6): 961–8. PMID 2067848.
- Saltman DL, Mellentin JD, Smith SD, Cleary ML (1991). "Mapping of translocation breakpoints on the short arm of chromosome 19 in acute leukemias by in situ hybridization.". Genes Chromosomes Cancer 2 (4): 259–65. PMID 2268576.
- Mellentin JD, Smith SD, Cleary ML (1989). "lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif.". Cell 58 (1): 77–83. PMID 2752424.
- Wadman I, Li J, Bash RO, et al. (1994). "Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia.". EMBO J. 13 (20): 4831–9. PMID 7957052.
- Trask B, Fertitta A, Christensen M, et al. (1993). "Fluorescence in situ hybridization mapping of human chromosome 19: cytogenetic band location of 540 cosmids and 70 genes or DNA markers.". Genomics 15 (1): 133–45. PMID 8432525.
- Miyamoto A, Cui X, Naumovski L, Cleary ML (1996). "Helix-loop-helix proteins LYL1 and E2a form heterodimeric complexes with distinctive DNA-binding properties in hematolymphoid cells.". Mol. Cell. Biol. 16 (5): 2394–401. PMID 8628307.
- Mahajan MA, Park ST, Sun XH (1996). "Association of a novel GTP binding protein, DRG, with TAL oncogenic proteins.". Oncogene 12 (11): 2343–50. PMID 8649774.
- Ferrier R, Nougarede R, Doucet S, et al. (1999). "Physical interaction of the bHLH LYL1 protein and NF-kappaB1 p105.". Oncogene 18 (4): 995–1005. doi:. PMID 10023675.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:. PMID 12477932.
- Grimwood J, Gordon LA, Olsen A, et al. (2004). "The DNA sequence and biology of human chromosome 19.". Nature 428 (6982): 529–35. doi:. PMID 15057824.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:. PMID 15489334.
- Meng YS, Khoury H, Dick JE, Minden MD (2005). "Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia.". Leukemia 19 (11): 1941–7. doi:. PMID 16094422.
[edit] External links
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

